Science Explorer Back to mapMap
Institution · Zambart

Most cited papers from Zambart

What are the most cited papers from Zambart?

The most cited paper from Zambart is "Stigma in health facilities: why it matters and how we can change it" (Laura C. Nyblade, Melissa Ann Stockton, Kayla Giger et al., 2019), with 899 citations. Next come "Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis" (623) and "Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries" (598).

Showing 50 of 60 papers. Every paper with more than 40 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Stigma in health facilities: why it matters and how we can change it Laura C. Nyblade, Melissa Ann Stockton, Kayla Giger et al. · BMC Medicine Open access 15 Feb 2019 899
2 Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis Dereck R. Tait et al. · New England Journal of Medicine Open access 29 Oct 2019 623
3 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Haileyesus Getahun et al. · European Respiratory Journal Open access 24 Sep 2015 598
4 Phase 2b Controlled Trial of M72/AS01 E Vaccine to Prevent Tuberculosis Olivier Van Der Meeren et al. · New England Journal of Medicine Open access 25 Sep 2018 425
5 Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells Ann L. N. Chapman, Mwansa Munkanta, Katalin Andrea Wilkinson et al. · AIDS Nov 2002 320
6 Stigma, HIV/AIDS and prevention of mother-to-child transmission in Zambia Virginia Anne Bond, Elaine Chase, Peter Aggleton · Evaluation and Program Planning 16 Oct 2002 209
7 Remote data collection for public health research in a COVID-19 era: ethical implications, challenges and opportunities Bernadette Hensen, Constance R. S. Mackworth-Young, Musonda Simwinga et al. · Health Policy and Planning Open access 24 Nov 2020 208
8 Community-based active case-finding interventions for tuberculosis: a systematic review Rachael M. Burke, Marriott Nliwasa, Helena R. A. Feasey et al. · The Lancet Public Health ReviewOpen access 23 Mar 2021 201
9 Patient‐reported barriers and drivers of adherence to antiretrovirals in sub‐Saharan Africa: a meta‐ethnography Sonja Merten, Elise Kenter, Oran Mckenzie et al. · Tropical Medicine & International Health 29 Apr 2010 196
10 ‘I will choose when to test, where I want to test’ Pitchaya Peach Indravudh, Euphemia Lindelwe Sibanda, Marc d’Elbée et al. · AIDS Open access 29 Jun 2017 183
11 What do the Universal Test and Treat trials tell us about the path to HIV epidemic control? Diane V. Havlir, Shahin Lockman, Helen Ayles et al. · Journal of the International AIDS Society Open access Feb 2020 155
12 A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial Richard Hayes, Sian Floyd, Ab Schaap et al. · PLoS Medicine Open access 2 May 2017 118
13 Community based distribution of oral HIV self-testing kits in Zambia: a cluster-randomised trial nested in four HPTN 071 (PopART) intervention communities Chama Mulubwa, Bernadette Hensen, Mwelwa Muleba Phiri et al. · The Lancet HIV Open access 21 Dec 2018 117
14 Can sexual health interventions make community-based health systems more responsive to adolescents? A realist informed study in rural Zambia Chama Mulubwa, Anna‐Karin Hurtig, Joseph Mumba Zulu et al. · Reproductive Health Open access 8 Jan 2020 112
15 Comparative assessment of five trials of universal HIV testing and treatment in sub‐Saharan Africa Delphine Perriat, Laura B. Balzer, Richard Hayes et al. · Journal of the International AIDS Society Open access 2018 110
16 The importance of addressing the unfolding TB‐HIV stigma in high HIV prevalence settings Virginia Anne Bond, Laura C. Nyblade · Journal of Community & Applied Social Psychology 25 Oct 2006 107
17 Delays in seeking, reaching and access to quality cancer care in sub-Saharan Africa: a systematic review Dorothy Chilambe Lombe, Monde Mwamba, Susan Msadabwe et al. · BMJ Open ReviewOpen access Apr 2023 95
18 Burnout and use of HIV services among health care workers in Lusaka District, Zambia: a cross-sectional study Gina Rae Kruse, Bushimbwa Tambatamba Chapula, Scott R. Ikeda et al. · Human Resources for Health Open access 13 Jul 2009 93
19 Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries Mishal Sameer Khan, Sonia Rego, Joaquín Benítez Rajal et al. · PLoS ONE Open access 2 Feb 2021 92
20 Chest X-ray Analysis With Deep Learning-Based Software as a Triage Test for Pulmonary Tuberculosis: An Individual Patient Data Meta-Analysis of Diagnostic Accuracy Gamuchirai Tavaziva, Miriam T. H. Harris, S.K. Abidi et al. · Clinical Infectious Diseases ReviewOpen access 20 Jul 2021 82
21 Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis Oliver Ratmann et al. · Nature Communications Open access 29 Mar 2019 82
22 ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial Helen Ayles, Charalambos Sismanidis, Nulda Beyers et al. · Trials Open access 7 Nov 2008 82
23 Costs of facility-based HIV testing in Malawi, Zambia and Zimbabwe Lawrence Mwenge, Linda Alinafe Sande, Collin Mangenah et al. · PLoS ONE Open access 16 Oct 2017 81
24 What impact do Global Health Initiatives have on human resources for antiretroviral treatment roll-out? A qualitative policy analysis of implementation processes in Zambia Johanna Hanefeld, Maurice Musheke · Human Resources for Health Open access 10 Feb 2009 80
25 Economic cost analysis of door‐to‐door community‐based distribution of HIV self‐test kits in Malawi, Zambia and Zimbabwe Collin Mangenah et al. · Journal of the International AIDS Society Open access Mar 2019 77
26 Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis Yohhei Hamada et al. · EClinicalMedicine ReviewOpen access 5 Jan 2023 75
27 Individual and community-level risk factors for HIV stigma in 21 Zambian and South African communities James Hargreaves, Shari Krishnaratne, Hlengani Mathema et al. · AIDS Open access 23 Jan 2018 72
28 Diabetes mellitus in Zambia and the Western Cape province of South Africa: Prevalence, risk factors, diagnosis and management Sarah Lou Bailey, Helen Ayles, Nulda Beyers et al. · Diabetes Research and Clinical Practice Open access 8 May 2016 72
29 Annual Risk of Tuberculous Infection Using Different Methods in Communities with a High Prevalence of TB and HIV in Zambia and South Africa Kwame Shanaube, Charalambos Sismanidis, Helen Ayles et al. · PLoS ONE Open access 12 Nov 2009 72
30 Defining adolescence: priorities from a global health perspective Anthony Kinghorn, Kwame Shanaube, Elona Toska et al. · The Lancet Child & Adolescent Health 23 Mar 2018 67
31 Development of parallel measures to assess HIV stigma and discrimination among people living with HIV, community members and health workers in the HPTN 071 (PopART) trial in Zambia and South Africa Anne L. Stangl, Pamela S. Lilleston, Hlengani Mathema et al. · Journal of the International AIDS Society Open access Dec 2019 66
32 Ability to understand and correctly follow HIV self‐test kit instructions for use: applying the cognitive interview technique in Malawi and Zambia Musonda Simwinga, Moses Kumwenda, Russell Dacombe et al. · Journal of the International AIDS Society Open access Mar 2019 65
33 The sensitivity of the QuantiFERON®-TB Gold Plus assay in Zambian adults with active tuberculosis Lily Telisinghe, Modupe Amofa-Sekyi, Kwitaka F. Maluzi et al. · The International Journal of Tuberculosis and Lung Disease Open access Jun 2017 64
34 Genital self-sampling compared with cervicovaginal lavage for the diagnosis of female genital schistosomiasis in Zambian women: The BILHIV study Amy S. Sturt, Emily L. Webb, Comfort Rutty Phiri et al. · PLoS neglected tropical diseases Open access 14 Jul 2020 63
35 Field comparison of OraQuick® ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia Dalila Zachary, Lawrence Mwenge, Monde Muyoyeta et al. · BMC Infectious Diseases Open access 8 Aug 2012 62
36 Ethical considerations in global HIV phylogenetic research Cordelia E. M. Coltart et al. · The Lancet HIV Open access 30 Aug 2018 61
37 “Being seen” at the clinic: Zambian and South African health worker reflections on the relationship between health facility spatial organisation and items and HIV stigma in 21 health facilities, the HPTN 071 (PopART) study Virginia Anne Bond, Sinazo Onela Nomsenge, Monde Mwamba et al. · Health & Place Open access 7 Dec 2018 59
38 Understanding the Time Needed to Link to Care and Start ART in Seven HPTN 071 (PopART) Study Communities in Zambia and South Africa the HPTN 071 (PopART) study team et al. · AIDS and Behavior Open access 10 Nov 2018 58
39 Risk Factors Associated with Positive QuantiFERON-TB Gold In-Tube and Tuberculin Skin Tests Results in Zambia and South Africa Kwame Shanaube, James Hargreaves, Katherine Fielding et al. · PLoS ONE Open access 4 Apr 2011 58
40 Barriers and outcomes: TB patients co-infected with HIV accessing antiretroviral therapy in rural Zambia Muatale Chileshe, Virginia Anne Bond · AIDS Care Jul 2010 58
41 When health data go dark: the importance of the DHS Program and imagining its future Jessie Jane Khaki et al. · BMC Medicine Open access 24 Apr 2025 57
42 “It is not an easy decision on HIV, especially in Zambia”: opting for silence, limited disclosure and implicit understanding to retain a wider identity Virginia Anne Bond · AIDS Care Jul 2010 57
43 Defining the research agenda to measure and reduce tuberculosis stigmas Karen MacIntyre et al. · The International Journal of Tuberculosis and Lung Disease Open access 13 Oct 2017 54
44 Using geospatial models to map zero-dose children: factors associated with zero-dose vaccination status before and after a mass measles and rubella vaccination campaign in Southern province, Zambia Rohan Arambepola, Yangyupei Yang, Kyle Hutchinson et al. · BMJ Global Health Open access Dec 2021 51
45 Community intervention improves knowledge of HIV status of adolescents in Zambia Kwame Shanaube, Ab Schaap, Mwate Joseph Chaila et al. · AIDS Open access 29 Jun 2017 51
46 HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa James Hargreaves, Anne L. Stangl, Virginia Anne Bond et al. · Health Policy and Planning Open access 3 Jul 2016 51
47 Stigma and Judgment Toward People Living with HIV and Key Population Groups Among Three Cadres of Health Workers in South Africa and Zambia: Analysis of Data from the HPTN 071 (PopART) Trial Shari Krishnaratne, Virginia Anne Bond, Anne L. Stangl et al. · AIDS Patient Care and STDs Open access 2020 49
48 Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia Sian Floyd, Helen Ayles, Ab Schaap et al. · PLoS ONE Open access 10 Aug 2018 48
49 Preferences for linkage to HIV care services following a reactive self-test Marc d’Elbée, Pitchaya Peach Indravudh, Lawrence Mwenge et al. · AIDS Open access 12 Jun 2018 48
50 HIV Stigma and Viral Suppression Among People Living With HIV in the Context of Universal Test and Treat: Analysis of Data From the HPTN 071 (PopART) Trial in Zambia and South Africa James Hargreaves, Triantafyllos Pliakas, Graeme Hoddinott et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes Open access 24 Sep 2020 46

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.